Lee Ainslie - Maverick Capital
Holding/activity history for Regeneron Pharmaceuticals (REGN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 1,758 | 0.03 | Buy | 0.03 | $878.27 |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2021 Q3 | 490 | 0.00 | Buy | 0.00 | $606.12 |
| 2020 Q4 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2020 Q3 | 588 | 0.01 | Buy | 0.01 | $559.52 |